Neuren Pharmaceuticals announced the appointment of Mr. Joe Basile as an independent non-executive director. Joe has held a number of executive roles in the pharmaceutical industry for over 30 years, most recently as Group CFO at iNova Pharmaceuticals based in Singapore and prior to that with Novartis in senior Finance leadership and Commercial Sales leadership roles in Australia and Asia. Joe has deep experience in corporate mergers and acquisitions, capital management and overseeing expansion activities across multiple countries with a sharp focus on shareholder value creation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.25 AUD | +3.22% | -0.16% | -22.91% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.91% | 1.55B | |
+25.83% | 661B | |
+26.82% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.85% | 231B | |
+5.22% | 200B | |
-8.88% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Appoints Joe Basile to Board of Directors